No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
NUS240517C12500
- 0.90
- +0.28+45.16%
15min DelayClose May 13 15:59 ET
0.90High0.90Low
0.90Open0.62Pre Close100 Volume295 Open Interest12.50Strike Price9.00KTurnover189.64%IV4.74%PremiumMay 17, 2024Expiry Date1.01Intrinsic Value100Multiplier4DDays to Expiry0.00Time Value100Contract SizeAmericanOptions Type0.6856Delta0.1277Gamma8.19Leverage Ratio-0.1224Theta0.0009Rho5.61Eff Leverage0.0052Vega
Intraday
- 5D
- 1D
News
Even After Rising 8.4% This Past Week, Nu Skin Enterprises (NYSE:NUS) Shareholders Are Still Down 75% Over the Past Three Years
Nu Skin Enterprises Repeat Insider Selling Not A Positive Indicator
Quite a few Nu Skin Enterprises, Inc. (NYSE:NUS) insiders sold their shares over the past year, which may be a cause for concern. Knowing whether insiders are buying is usually more helpful when eva
Nu Skin Enterprises Inc (NUS) Q1 Earnings: Aligns With EPS Projections Amidst Revenue Decline
Nu Skin Enterprises | 10-Q: Quarterly report
Nu Skin Is Maintained at Neutral by DA Davidson
Nu Skin Is Maintained at Neutral by DA Davidson
Nu Skin Enterprises Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/09/2024 0.93% DA Davidson $15.5 → $12.5 Maintains Neutral 01/05/2024 69.56% DA Davidson $29 → $21 Maint
Comments
Nu Skin Enterprises' low P/S ratio is likely due to anticipated poor revenue performance. Its shrinking revenues and weak outlook, contrasting with expected industry growth, justify its low P/S ratio and hint at a stagnant share price.
Benign Growth For Nu Skin Enterprises, Inc. (NYSE:NUS) Underpins Stock's 28% PlummetAnalysts are more bearish on Nu Skin Enterprises' prospects, with a significant cut to revenue and EPS estimates. The company's slower expected revenue growth compared to the wider market could worry investors.
Despite a mixed Q3, personal care stocks have held their ground better than other sectors, with share prices up 18.5% on average since the previous earnings results. Coty's stock is up 20.9%, Olaplex's stock is up 74.6%, Nu Skin's stock is down 0.1%, Herbalife's stock is down 9.8%, and BellRing Brands' stock is up 22.3%.
Read more